Dilawar Khan

Islamabad, IS 44000, Pakistan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Retraction notice to "A nanoformulation of cisplatin with arabinoxylan having enhanced activity against hepatocellular carcinoma through upregulation of apoptotic and necroptotic pathways" [Heliyon 10 (2024) e31057].

Retraction notice to "A nanoformulation of cisplatin with arabinoxylan having enhanced activity against hepatocellular carcinoma through upregulation of apoptotic and necroptotic pathways" [Heliyon 10 (2024) e31057].

Journal: Heliyon
Published: August 12, 2026

Development of metal-free one-pot sequential synthesis of carbazolyl-thiazolidinones as anti-leukemic agents with potential β-catenin/c-MYC pathway modulation: from synthesis to in vitro and in silico profiling.

Development of metal-free one-pot sequential synthesis of carbazolyl-thiazolidinones as anti-leukemic agents with potential β-catenin/c-MYC pathway modulation: from synthesis to in vitro and in silico profiling.

Journal: Bioorganic chemistry
Published: May 30, 2026

Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy.

Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy.

Journal: BMC cancer
Published: June 28, 2025

TAM family kinases are potential candidate targets for therapeutic intervention in chronic myeloid leukemia.

TAM family kinases are potential candidate targets for therapeutic intervention in chronic myeloid leukemia.

Journal: Discover oncology
Published: June 27, 2025

Anticancer role of Gramicidin A in myeloid leukemia.

Anticancer role of Gramicidin A in myeloid leukemia.

Journal: Discover oncology
Published: March 23, 2025

Zapotin mitigates breast cancer progression by targeting PKCε mediated glycolytic pathway regulation.

Zapotin mitigates breast cancer progression by targeting PKCε mediated glycolytic pathway regulation.

Journal: BMC cancer
Published: January 28, 2025

Investigating the pathogenic potential of PKC-eta UTR variants in cancer progression.

Investigating the pathogenic potential of PKC-eta UTR variants in cancer progression.

Journal: Computers in biology and medicine
Published: January 20, 2025

Imidazolium, pyridinium and pyrazinium based ionic liquids with octyl side chains as potential antibacterial agents against multidrug resistant uropathogenic E. coli.

Imidazolium, pyridinium and pyrazinium based ionic liquids with octyl side chains as potential antibacterial agents against multidrug resistant uropathogenic E. coli.

Journal: Heliyon
Published: May 27, 2024

Effects of imidazole derivatives on cellular proliferation and apoptosis in myeloid leukemia.

Effects of imidazole derivatives on cellular proliferation and apoptosis in myeloid leukemia.

Journal: BMC cancer
Published: December 18, 2023

A nanoformulation of cisplatin with arabinoxylan having enhanced activity against hepatocellular carcinoma through upregulation of apoptotic and necroptotic pathways.

A nanoformulation of cisplatin with arabinoxylan having enhanced activity against hepatocellular carcinoma through upregulation of apoptotic and necroptotic pathways.

Journal: Heliyon
Published: November 19, 2023

Silencing of Curlin Protein via M13 Phagemid-Mediated Synthetic sRNA Expression Reduces Virulence in the Avian Pathogenic E. coli (APEC).

Silencing of Curlin Protein via M13 Phagemid-Mediated Synthetic sRNA Expression Reduces Virulence in the Avian Pathogenic E. coli (APEC).

Journal: Current microbiology
Published: May 07, 2021

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.

Journal: BMC cancer
Published: December 23, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026